The vaccines space has traditionally been the preserve of a select group of companies but the pandemic has changed it all quite markedly, at least in India.
There’s been a stream of conventionally non-vaccine biopharma firms keen to tap into the segment, essentially via alliances for now. Whether these are just opportunistic decisions or a testing ground...